Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
Han Joo Baek, Mie Jin Lim, Won Park, Sung Hwan Park, Seung-Cheol Shim, Dae-Hyun Yoo, Hyun Ah Kim, Soo Kon Lee, Yun Jong Lee, Young Eun Park, Hoon-Suk Cha, Yeong-Wook Song
Korean J Intern Med. 2019;34(4):917-931.   Published online 2018 Jan 17     DOI: https://doi.org/10.3904/kjim.2017.159
Citations to this article as recorded by Crossref logo
Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs
Dala N Daraghmeh, Ashley M Hopkins, Catherine King, Ahmad Y Abuhelwa, Mihir D Wechalekar, Susanna M Proudman, Michael J Sorich, Michael D Wiese
Rheumatology.2023; 62(2): 583.     CrossRef
Research on Liver Damage Caused by the Treatment of Rheumatoid Arthritis with Novel Biological Agents or Targeted Agents
Xin Zhao, Chenhao Zhang, Yi An, Zixuan Zhang, Jiahe Zhao, Xinwen Zhang, Yue Yang, Wei Cao
Journal of Inflammation Research.2023; Volume 16: 443.     CrossRef
Chemokines and chemokine receptors as promising targets in rheumatoid arthritis
Masanori A. Murayama, Jun Shimizu, Chie Miyabe, Kazuo Yudo, Yoshishige Miyabe
Frontiers in Immunology.2023;[Epub]     CrossRef
Targeting IL-6 Signaling Pathways for Musculoskeletal Disorders Treatment: Risks and Benefits
Aisha Muthanna Shanshal, Raghda Hisham Aljorani, Saad Abdulrahman Hussain
Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ).2023; 4: 34.     CrossRef
Comparative Efficacy of bDMARDs and tsDMARDs for the Treatment of Rheumatoid arthritis: A Systematic Review and Network Meta-Analysis
Penghua Shi, Li Wang, Jiafang He, Yun Lu
International Journal of Biology and Life Sciences.2023; 3(1): 35.     CrossRef
Effectiveness of biologics and targeted synthetic disease‐modifying anti‐rheumatic drugs in conjunction with methotrexate for the treatment of early rheumatoid arthritis: A systematic review of randomized controlled trials
Sadia Laeeq, Tiba Reghefaoui, Hafsa Zahoor, Ji Hyun Yook, Muneeba Rizwan, Noor ul ain Shahid, Noreen Naguit, Rakesh Jakkoju, Lubna Mohammed
Musculoskeletal Care.2022; 20(3): 471.     CrossRef
Evaluation of Treatment with a single (400mg) versus double dose (800mg) of Tocilizumab in Acute Respiratory Distress Syndrome Associated with COVID-19Pneumonia
Barış ÇİL, Mehmet KABAK
Journal of Contemporary Medicine.2022; 12(1): 134.     CrossRef
Evaluation of Serum Matrix Metalloproteinase-3 as an Objective Indicator for the Disease Activity in Rheumatoid Arthritis Patients Treated With Methotrexate Versus Tocilizumab: 24-week Results From a Prospective Randomized Controlled Study
Jina Yeo, Han Joo Baek, Yeong Wook Song, Eun Young Lee
Journal of Rheumatic Diseases.2022; 29(2): 89.     CrossRef
Predictive Factors for Rheumatoid Arthritis Flare After Switching From Intravenous to Subcutaneous Formulation of Tocilizumab in Real-World Practice
Soo Min Ahn, Ji Seon Oh, Hyun Mi Heo, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim
Journal of Korean Medical Science.2022;[Epub]     CrossRef
Patient Preference for Self-Injection Devices in Rheumatoid Arthritis: A Discrete Choice Experiment in China
Yan Wei, Jin Zhao, Jian Ming, Xuewu Zhang, Yingyao Chen
Patient Preference and Adherence.2022; Volume 16: 2387.     CrossRef
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases
Kastriot Kastrati, Daniel Aletaha, Gerd R Burmester, Eva Chwala, Christian Dejaco, Maxime Dougados, Iain B McInnes, Angelo Ravelli, Naveed Sattar, Tanja A Stamm, Tsutomu Takeuchi, Michael Trauner, Desirée van der Heijde, Marieke J H Voshaar, Kevin Winthro
RMD Open.2022; 8(2): e002359.     CrossRef
Rituximab, a Safer Option for Rheumatoid Arthritis: A Comparison of the Reported Adverse Events of Approved Monoclonal Antibodies
Sweety Sharma, Somnath Basu, Ramesh K. Goyal, Parbhat K. Sahoo, Rajani Mathur
Journal of Pharmacology and Pharmacotherapeutics.2022; 13(4): 330.     CrossRef
The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek, Jisoo Lee
The Korean Journal of Internal Medicine.2020; 35(1): 41.     CrossRef
The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus
Eun-Jung Park, Hyungjin Kim, Seung Min Jung, Yoon-Kyoung Sung, Han Joo Baek, Jisoo Lee
Journal of Rheumatic Diseases.2020; 27(1): 4.     CrossRef
Tocilizumab Increases Body Weight and Serum Adipokine Levels in Patients with Rheumatoid Arthritis Independently of their Treatment Response: a Retrospective Cohort Study
In Ah Choi, Akira Sagawa, Eun Young Lee, Eun Bong Lee, Yeong Wook Song
Journal of Korean Medical Science.2020;[Epub]     CrossRef
Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literature
Luca Bernardo, Stefania Del Sesto, Laura Giordano, Anna Rita Benincaso, Piero Biondi, Vinicio Goj, Francesca Ferrara, Antonella Talenti, Antonella Grisolia, Paolo Antonio Ascierto
Drugs & Therapy Perspectives.2020; 36(12): 568.     CrossRef
Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications
Sarah Patterson, Gabriela Schmajuk, Michael Evans, Ishita Aggarwal, Zara Izadi, Milena Gianfrancesco, Jinoos Yazdany
The Joint Commission Journal on Quality and Patient Safety.2019; 45(5): 348.     CrossRef
Disseminated nocardiosis with Nocardia brasiliensis bacteremia in a patient with rheumatoid arthritis using tocilizumab
Ryosuke Yamate, Takashi Matono, Takashi Yaguchi, Yusuke Fujii, Yuki Goto, Kazunori Tobino, Hiroshi Imura, Shuji Nagano
Journal of Infection and Chemotherapy.2019; 25(7): 552.     CrossRef
Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors
Jawad Bilal, Adam Berlinberg, Irbaz Bin Riaz, Warda Faridi, Sandipan Bhattacharjee, Gilbert Ortega, Mohammad H. Murad, Zhen Wang, Larry J. Prokop, Abdullah A. Alhifany, C. Kent Kwoh
JAMA Network Open.2019; 2(10): e1913102.     CrossRef
Early Response of DAS28-ESR (3) Predicts Sustained Response to Tocilizumab Switched from Abatacept
Takayasu Ando, Takeshi Suzuki, Yutaka Gotou, Mitsuru Imamura, Hiroko Nagafuchi, Yoshioki Yamasaki, Seido Ooka, Kimito Kawahata
Journal of St. Marianna University.2019; 10(2): 39.     CrossRef